中文
|
English
Home
|
Help
|
Contact
Return
Adalimumab or infliximab: which is better for perianal fistula in Crohn's disease?.
10.5217/ir.2017.15.2.147
Author:
Jong Pil IM
1
Author Information
1. Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea. jpim0911@snu.ac.kr
Publication Type:
Editorial
MeSH:
Adalimumab*; Crohn Disease*; Fistula*; Infliximab*
From:
Intestinal Research 2017;15(2):147-148
Country
Republic of Korea
Language:
English
Abstract:
No abstract available.